Sarpagandha ghanvati will be given to patients of High blood pressure
Phase 2
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2023/07/055053
- Lead Sponsor
- MANISHA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of either sex with age between 18-70 years
Patients having Systolic Blood Pressure is more than 140 and less than 180 mm of Hg
Patients having Diastolic Blood Pressure is more than 90 and less than or equal to 110 mm of Hg
Exclusion Criteria
Patients of either sex below 18 years & above 70 years will be excluded from the study
Patients having Systolic Blood Pressure is more than 180mm of Hg
Patients having Diastolic Blood Pressure is more than 110mmHg
Patients suffering from serious comorbidities like Renal failure, Coronaryartery disease, endocrinal disorder, congestive heart disease
Pregnant woman
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method a) Headache <br/ ><br>b) Giddiness <br/ ><br>c) Palpitations <br/ ><br>d) Breathlessness <br/ ><br>e) Insomnia <br/ ><br>Timepoint: Assessment willl be done weekly for 8 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method 1. systolic blood pressure <br/ ><br>2. diastolic blood pressureTimepoint: Assessment of the patients will be done weekly for 8 weeks